High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study

References

• Castanotto D , RossiJJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature457(7228), 426–433 (2009).
   PubMed Web of Science ®Google Scholar
• Tremblay GA , OldfieldPR. Bioanalysis of siRNA and oligonucleotides therapeutics in biological fluids and tissues. Bioanalysis1(3), 595–609 (2009).
   PubMed Web of Science ®Google Scholar
• Sahu NK , ShilakariG, NayakA, KohliDV. Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr. Pharm. Biotechnol.8(5), 291–304 (2007).
   PubMed Web of Science ®Google Scholar
• Presner JR , ChinnaiyanAM. The emergence of IncRNAs in cancer biology. Cancer Discov.1(5), 391–407 (2011).
   PubMed Web of Science ®Google Scholar
• Sharbati-Tehrani S , Kutz-LohroffB, BergbauerR, ScholvenJ, EinspanierR. miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol. Biol.9, 34 (2008).
   PubMed Web of Science ®Google Scholar
• Eckstein F . Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?Antisense Nucleic Acid. Drug Dev.10(2), 117–121 (2000).
   PubMedGoogle Scholar
• Sayers JR , OlsenDB, EcksteinF. Inhibition of restriction endonuclease hydrolysis by phosphorothioate-containing DNA. Nucleic Acids Res.17(22), 9495 (1989).
   PubMed Web of Science ®Google Scholar
• Bartlett MG , KimJ, BasiriB, LiN. Sample preparation for LC-MS bioanalysis of oligonucleotides. In: Sample Preparation in LC-MS Bioanalysis.LiW, JianW, FuY ( Eds). John Wiley & Sons, Inc, NJ, USA, 319–334 (2019).
   Google Scholar
• Ewles M , GoodwinL, SchneiderA. Rothhammer-Hampl Quantification of oligonucleotides by LC-MS/MS: the challenges of quantifying a phophorothioate oligonucleotide and multiple metabolites. Bioanalysis6(4), 447–464 (2014).
   PubMed Web of Science ®Google Scholar
• Brown DA , KangSH, GryaznovSM. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem.269(43), 26801–26805 (1994).
   PubMed Web of Science ®Google Scholar
• Husser C , BrinkA, ZellM, MullerM, KollerE, SchadtS. Identification of GAlNAc-conjugated antisense oligonucleotide metabolites using an untargeted and generic approach based on high resolution mass spectrometry. Anal. Chem.89, 6821–6826 (2017).
   PubMed Web of Science ®Google Scholar
• Kanasty R , KorkinJR, VegasA, AndersonD. Delivery materials for siRNA therapeutics. Nat. Mater.12(11), 967–977 (2013).
   PubMed Web of Science ®Google Scholar
• Ming X , LaingB. Bioconjugates for targeted delivery of therapeutic oligonucleotides. Adv. Drug Deliv. Rev.87, 81–89 (2015).
   PubMed Web of Science ®Google Scholar
• Prakash TP , GrahamM, YuJet al. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res.42(13), 8796–8807 (2014).
   PubMed Web of Science ®Google Scholar
• Studzinska S . Review on investigations of antisense oligonucleotides with the use of mass spectrometry. Talanta176, 329–343 (2018).
   PubMed Web of Science ®Google Scholar
• Van Dongen W , NiessenW. Bioanalytical LC-MS of therapeutic oligonucleotides. Bioanalysis3(5), 541–564 (2011).
   PubMed Web of Science ®Google Scholar
• Wang L , JiC. Advances in quantitative bioanalysis of oligonucleotide biomarkers and therapeutics. Bioanalysis8(2), 143–155 (2016).
   PubMed Web of Science ®Google Scholar
• Wang L , MengM, ReuschelS. Regulated bioanalysis of oligonucleotide therapeutics and biomarkers: qPCR versus chromatographic assays. Bioanalysis5(22), 2747–2751 (2013).
   PubMed Web of Science ®Google Scholar
• Basiri B , BartlessMG. LC-MS of oligonucleotides: applications in biomedical research. Bioanalysis6(11), 1525–1542 (2014).
   PubMed Web of Science ®Google Scholar
• Bartlett M , ChenB, McGinnisC. LC-MS bioanalysis of oligonucleotides. In: Handbook of LC-MS Bioanalysis.LiW, ZhangJ, TseF ( Eds). John Wiley & Sons, Inc, NJ, USA, 607–627 (2013).
   Google Scholar
• Hemsley M , EwlesM, GoodwinL. Development of a bioanalytical method for quantification of a 15-mer oligonucleotide at sub-ng/ml concentrations using LC-MS/MS. Bioanalysis4(12), 1457–1469 (2012).
   PubMed Web of Science ®Google Scholar
• Sun Y , NittaS, SaitoKet al. Development of a bioanalytical method for an antisense therapeutic using high-resolution mass spectrometry. Bioanalysis12(24), 1739–1756 (2020).
   PubMed Web of Science ®Google Scholar
• Prakash TP , GrahamMJ, YuJet al. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res.42(13), 8796–8807 (2014).
   PubMed Web of Science ®Google Scholar
• Cohen JC , PertsemlidisA, KotowskiIK, GrahamR, GarciaCK, HobbsHH. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet.37(2), 161–165 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen JC , BoerwinkleE, MosleyTH, HobbsHH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med.354(12), 1264–1272 (2006).
   PubMed Web of Science ®Google Scholar
• Rudge J , ScottG, HailM, McginleyM. Preparation and LC-MS analysis of oligonucleotide therapeutics from biological matrices. Chromatogr. Today16–20 (2011).
   Google Scholar
• Chen B , BartlettMA. One-step solid phase extraction method for bioanalysis of a phophorothioate oligonucleotide and its 3’ n-1 metabolite from rat plasma by uHPLC-MS/MS. AAPS J.14(4), 772–780 (2012).
   PubMed Web of Science ®Google Scholar
• Nuckowski L , KaczmarkiewiczA, StudzinskaS. Development of SPE method for the extraction of phosphorothioate oligonucleotides from serum samples. Bioanalysis10(20), 1667–1677 (2018).
   PubMed Web of Science ®Google Scholar
• Studzinska S , RolaR, BuszewskiB. Development of a method based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry for studying the in vitro metabolism of phophorothioate oligonucleotides. Anal. Bioanal. Chem.408(6), 1585–1595 (2016).
   PubMed Web of Science ®Google Scholar
• Beverly M , HartsoughK, MachemerL, PavcoP, LockridgeJ. Liquid chromatography electrospray ionization mass spectrometry analysis of the ocular metabolites from a short interfering RNA duplex. J. Chromatogr. B835(1-2), 62–70 (2006).
   PubMed Web of Science ®Google Scholar
• Chen B , BartlettMG. Evaluation of mobile phase composition for enhancing sensitivity of targeted quantification of oligonucleotides using ultra-high performance liquid chromatography and mass spectrometry: application to phosphorothioate deoxyribonucleic acid. J. Chromatogr. A1288, 73–81 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang G , LinJ, SrinivasanK, KavetskaiaO, DuncanJN. Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem mass spectrometry. Anal. Chem.79(9), 3416–3424 (2007).
   PubMed Web of Science ®Google Scholar
• McGinnis A , GrubbE, BartlettM. Systematic optimization of ion-pairing agents and hexafluoroisopropanol for enhanced electrospray ionization mass spectrometry of oligonucleotides. Rapid Commun. Mass Spectrom.27, 2655–2664 (2013).
   PubMed Web of Science ®Google Scholar
• Apffel A , ChakelJ, FisherS, LichtenwalterK, HancockW. New procedure for the use of high-performance liquid chromatography-electrospray ionization mass spectrometry for the analysis of nucleotides and oligonucleotides. J. Chromatogr. A777, 3–21 (1997).
   Web of Science ®Google Scholar
• Apffel A , ChakelJ, FisherS, LichtenwalterK, HancockW. Analysis of oligonucleotides by HPLC-electrospray ionization mass spectrometry. Anal. Chem.69(7), 1320–1325 (1997).
   PubMed Web of Science ®Google Scholar
• Gilar M , FountainK, BudmanY, YolyokeJL, DavoudiH, GeblerJC. Characterization of therapeutic oligonucleotides using liquid chromatography with on-line mass spectrometry detection. Oligonucleotides13(4), 229–243 (2003).
   PubMedGoogle Scholar
• Birdsall R , GilarM, ShionH, QingY, ChenW. Reduction of metal adducts in oligonucleotide mass spectra in ion-pair reversed-phase chromatography/mass spectrometry analysis. Rapid Commun. Mass Spectrom.30(14), 1667–1679 (2016).
   PubMed Web of Science ®Google Scholar
• US FDA. Guidance for industry: bioanalytical method validation. US Department of Health and Human Services, US FDA.MD, USA.http://www.fda.gov
   Google Scholar
• The European Medicines Agency (EMA), Committee for Medicinal Products for Human Use. Guideline on bioanalytical method validation (2011). http://www.ema.europe.eu
   Google Scholar